Development and Validation of the ALARN Model: A Predictive Mortality Score for Antisynthetase Syndrome
Listen to this summary
The authors aimed to develop and validate a prognostic model, the ALARN score, for predicting all-cause mortality in patients with antisynthetase syndrome (ASyS). Utilizing data from 1194 patients, they identified five key prognostic factors and created a simplified scoring system that effectively stratifies patients into risk categories, demonstrating strong predictive performance in both internal and external validation cohorts. The ALARN score offers a practical tool for clinicians to assess mortality risk in ASyS patients.
This is one of 33,000+ journals available on OSLR. Try it free for 14 days.
Free 14-day trial. 33,000+ journals. Cancel anytime.

More from Arthritis & rheumatology (Hoboken, N.J.)
View all →Jun 11, 2026 · Arthritis & rheumatology (Hoboken, N.J.)
Distinct molecular pathways supporting Sjögren's Disease clusters and disease progression
Jun 8, 2026 · Arthritis & rheumatology (Hoboken, N.J.)
Homocitrullinated Peptides Drive Pro-Inflammatory T-Cell Responses in a Humanized Mouse Model of Rheumatoid Arthritis
Jun 4, 2026 · Arthritis & rheumatology (Hoboken, N.J.)
Multimodal peripheral blood immunophenotyping and single cell epigenetic analysis of knee osteoarthritis reveals expansion and epigenetic dysregulation of regulatory T-cell and nonclassical monocyte populations
Jun 3, 2026 · Arthritis & rheumatology (Hoboken, N.J.)
Fine particulate matter constituents, ozone, and systemic lupus erythematosus: A large general-population cohort analysis with extended quantile g-computation
Jun 1, 2026 · Arthritis & rheumatology (Hoboken, N.J.)
Integrated Clinical and Proteomic Profiling of CD19 CAR-T Cell Therapy in Progressive Systemic Sclerosis
Jun 1, 2026 · Arthritis & rheumatology (Hoboken, N.J.)
Human Fibroblast-Myeloid cell tissue atlas across lung, synovium, skin and heart
More in Pediatrics
View all →Jun 25, 2026 · Blood
Combining Quizartinib with intensive chemotherapy in older patients with newly diagnosed AML: results of the UK NCRI AML18 Trial
Jun 25, 2026 · Blood
Translational Regulation of Sf1 Integrates Alternative Splicing and Hematopoietic Stem Cell Fate
Jun 25, 2026 · The American journal of sports medicine
Association of Central Acetabular Osteophytes With Microinstability and Increased Combined Anteversion in Borderline Dysplasia Hips
Jun 25, 2026 · Blood
Galectin-1 Fuels Monocyte Hyperinflammation and Represents a Novel Therapeutic Target in Myeloproliferative Neoplasms
Jun 25, 2026 · Blood
NG2-ITGA4 axis regulates Rho GTPases and leukemic aggressiveness in KMT2A-r B-ALL and is targetable with natalizumab
Jun 24, 2026 · Critical care medicine
Ethical Implications of the Slow Code: A Systematic Review of Ethics of Slow Codes in U.S. Hospitals
"Oslr has become part of my weekly routine on my day off. The clinical relevance of the summaries is outstanding — I'd rate it 9/10. Being able to consume research hands-free is a huge advantage for busy physicians."
Dr. Jennifer Thompson
Portland, OR


